Geoffrey Cockrell

Jan 23, 2025 | mondaq.com | Geoffrey Cockrell

McGuireWoods partner Kevin Madagan offersprivate equity investors a window into the future of the lifesciences industry in this wide-ranging conversation with partnerand host Geoff Cockrell. From the FDA's new Advisory Committee for Digital Health tothe controversial Biosecure Act, which could open avenues forinvestors in the life sciences sector, Kevin suggests news forinvestors to monitor.

Jan 13, 2025 | mondaq.com | Geoffrey Cockrell

McGuireWoods partner and host Geoff Cockrell and associate Amanda Roenius welcome JessicaNunn, CEO of Maven Financial Partners, for a discussionabout the convergence of med spas and private equity. Jessica describes key characteristics of the med spa arena,different membership models and drivers of profitability andexplains why she expects the space to be more competitive in2025. The content of this article is intended to provide a generalguide to the subject matter.

Jan 7, 2025 | mondaq.com | Geoffrey Cockrell

An affiliate of New Enterprise Associates (NEA) will acquireNeueHealth for approximately $1.3 billion, according to a news release. NeueHealth (NYSE: NEUE), founded in 2015 andbased in Doral, Florida, operates clinics under the brand names ofCentrum Health, AssociatesMD and Premier Medical Associates. Thecompany also provides a suite of technology and services toindependent providers and medical groups.

Dec 31, 2024 | jdsupra.com | Geoffrey Cockrell

An affiliate of New Enterprise Associates (NEA) will acquire NeueHealth for approximately $1.3 billion, according to a news release. NeueHealth (NYSE: NEUE), founded in 2015 and based in Doral, Florida, operates clinics under the brand names of Centrum Health, AssociatesMD and Premier Medical Associates. The company also provides a suite of technology and services to independent providers and medical groups.

Dec 12, 2024 | jdsupra.com | Geoffrey Cockrell

Valeas Capital Partners has announced the closing of its first institutional fund at more than $600 million. The inaugural fund, VCP Fund I, exceeded its target. Valeas, founded in 2021 and based in San Francisco, is a middle-market, growth-buyout private equity firm. The firm prefers to invest between $50 million and $150 million in companies operating in healthcare and a few other sectors.